These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 15602384
21. CD4+/CD56+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha). Piña-Oviedo S, Herrera-Medina H, Coronado H, Del Valle L, Ortiz-Hidalgo C. Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):481-6. PubMed ID: 18091395 [Abstract] [Full Text] [Related]
22. CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC). Petrella T, Dalac S, Maynadié M, Mugneret F, Thomine E, Courville P, Joly P, Lenormand B, Arnould L, Wechsler J, Bagot M, Rieux C, Bosq J, Avril MF, Bernheim A, Molina T, Devidas A, Delfau-Larue MH, Gaulard P, Lambert D. Am J Surg Pathol; 1999 Feb; 23(2):137-46. PubMed ID: 9989839 [Abstract] [Full Text] [Related]
28. Clinicopathological analysis of 46 cases with CD4+ and/or CD56+ immature haematolymphoid malignancy: reappraisal of blastic plasmacytoid dendritic cell and related neoplasms. Suzuki Y, Kato S, Kohno K, Satou A, Eladl AE, Asano N, Kono M, Kato Y, Taniwaki M, Akiyama M, Nakamura S. Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410 [Abstract] [Full Text] [Related]
32. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate. Leitenberger JJ, Berthelot CN, Polder KD, Pro B, McLaughlin P, Jones D, Duvic M. J Am Acad Dermatol; 2008 Mar; 58(3):480-4. PubMed ID: 18280345 [Abstract] [Full Text] [Related]
33. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study]. Sang W, Wang CF, Cheng YF, Liu X, Li XX, Gulinar A, Li JZ, Zhang W. Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):326-30. PubMed ID: 22883672 [Abstract] [Full Text] [Related]